Skip to search formSkip to main contentSkip to account menu

YM 529

Known as: ONO-5920, YM-529, YM529 
National Institutes of Health

Related topics

Related topics

4 relations

Broader (3)

DiphosphonatesImidazolesMinodronic Acid
YH 529

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
A novel third generation bisphosphonate, minodronate (YM529), prevented proliferation and migration of hepatocellular carcinoma cells through inhibition of mevalonate pathway
Aim:  Skeletal metastases and bone metasitasis are a common occurrence in patients with advanced hepatocellular carcinoma (HCC… 
2007
2007
Induction of mitochondria-dependent apoptosis through the inhibition of mevalonate pathway in human breast cancer cells by YM529, a new third generation bisphosphonate.
2007
2007
The bisphosphonate YM529 inhibits osteoblastic bone tumor proliferation of prostate cancer
In men, prostate cancer frequently metastasizes to the bones, where it forms osteoblastic lesions with an osteolytic element that… 
2006
2006
The third-generation bisphosphonates inhibit proliferation of murine osteosarcoma cells with induction of apoptosis.
2005
2005
A Third-Generation Bisphosphonate, Minodronic Acid (YM529), Augments the Interferon α/β-Mediated Inhibition of Renal Cell Cancer Cell Growth Both In vitro and In vivo
Purpose: Minodronic acid (YM529) is a third-generation nitrogen-containing bisphosphonate. Here, we have investigated the… 
2005
2005
Effect of Combination Therapy with a Novel Bisphosphonate, Minodronate (YM529), and Docetaxel on a Model of Bone Metastasis by Human Transitional Cell Carcinoma
Purpose: Transitional cell carcinoma (TCC) of the urinary tract is a chemosensitive tumor. Most deaths from TCC of the urinary… 
2005
2005
A third-generation bisphosphonate, minodronic acid (YM529), augments the interferon alpha/beta-mediated inhibition of renal cell cancer cell growth both in vitro and in vivo.
PURPOSE Minodronic acid (YM529) is a third-generation nitrogen-containing bisphosphonate. Here, we have investigated the… 
2003
2003
A new bisphosphonate, YM529 induces apoptosis in HL60 cells by decreasing phosphorylation of single survival signal ERK.
2003
2003
Effect of minodronic acid (ONO-5920) on bone mineral density and arthritis in adult rats with collagen-induced arthritis.
OBJECTIVE To study the effect of minodronic acid (ONO-5920) on bone loss and arthritis in rats with collagen-induced arthritis… 
1994
1994
Sensitive determination of a novel bisphosphonate, YM529, in plasma, urine and bone by high-performance liquid chromatography with fluorescence detection.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)